Retina Group of Florida

What Retina Group of Florida does

Retina Group of Florida is a private, retina-only ophthalmology practice founded in 1986 and headquartered in Fort Lauderdale, Florida, operating 25 clinic locations across the state's East, Gulf, and West coasts with a team of 27 retina specialists supported by 101-250 employees. The practice delivers diagnostic imaging, medical management, and vitreoretinal surgery for the full spectrum of retinal conditions, including age-related macular degeneration (wet and dry), diabetic retinopathy, retinal tears and detachments, macular holes and puckers, uveitis, and vascular occlusions. Core service lines include intravitreal injections using agents such as Avastin, Eylea, Lucentis, and Iluvien implants, vitrectomy and scleral buckle surgery, photocoagulation and photodynamic laser therapy, clinical diagnostic imaging, and an active clinical trials program conducted through a fully staffed retina research center.

The practice pairs clinical delivery with proprietary and specialty tooling: Dr. Dan P. Montzka developed custom electronic medical software used across the practice, and the group holds a US patent (April 2001) for an apparatus, system, and method for securing scleral tissue during retina surgery. In 2020, the practice joined Retina Consultants of America, a national consortium of elite retina-only practices, gaining access to shared research infrastructure, clinical trial pipelines, and the RCA Insights data and AI division (for which Dr. Hasenin Al-khersan serves as medical director). In 2025, the practice combined with Retina Consultants of Southwest Florida, adding three additional physicians, and in 2026 it launched Photobiomodulation Therapy for Dry AMD, expanding its treatment menu beyond injections and surgery.

Revenue is generated primarily through direct patient care services billed via insurance claims and patient payments, supplemented by participation in clinical research trials. The practice supports ten languages on its website, operates a MyPatientVisit patient portal for scheduling and records access, maintains a formal physician referral network, runs a retinal fellowship program, and offers a dedicated international patient coordinator with travel and lodging arrangements. Pricing is not publicly disclosed; the practice accepts most insurance plans and complies with HIPAA and partial WCAG 2.1 Level AA accessibility requirements. A November 2024 data breach affecting approximately 153,000 patients is disclosed in historical records but has not altered the practice's ownership or operating status.

Name

Retina Group of Florida

Legal name

Retina Group of Florida

Website

https://retinagroupflorida.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

101–250 employees

Short description

Retina Group of Florida is a private retina-only ophthalmology practice founded in 1986, operating 25 Florida clinic locations with 27 specialists to diagnose and surgically treat macular degeneration, diabetic retinopathy, retinal detachments, and related vitreoretinal conditions.

Ownership category

akta.pro rank

Product category

Retinal and Vitreoretinal Ophthalmology Care

NAICS

Offices of Optometrists (62132), Offices of Optometrists (621320)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

Keywords

• Retina care services
• Vitreoretinal surgery
• Ophthalmology practice
• Intravitreal injections
• Retinal diagnostics

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices25 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Patient Care Services: Direct medical services to patients including diagnostic examinations, treatments, and surgical procedures for retinal conditions. Revenue generated through insurance claims and patient payments.
2. Clinical Trial Participation: Participation in clinical trials for new retinal treatments and therapies, contributing to FDA approval processes.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Retina Group of Florida is a retina-only ophthalmology practice providing diagnostic, medical, and surgical care for retinal, macular, and vitreoretinal conditions across 25 Florida locations. The practice delivers intravitreal injection therapies, vitreoretinal surgeries (vitrectomy, scleral buckle, Iluvien implants), laser treatments, and newly available Photobiomodulation Therapy for Dry AMD, alongside an active clinical trials research program. It serves both direct patients and physician referrals with multilingual support across 10 languages.

Product overview

Retina Group of Florida is a retina-only ophthalmology practice providing comprehensive medical and surgical care for the full spectrum of retinal, macular, and vitreoretinal conditions. The practice operates as a single unified healthcare service offering with 25 convenient Florida locations. Core offerings include diagnostic services, intravitreal injection therapies (Avastin, Eylea, Lucentis), surgical procedures (vitrectomy, scleral buckle), laser treatments, and the newly available Photobiomodulation Therapy for Dry AMD. The practice also maintains an active clinical trial research program and provides a patient portal for access to medical records. In 2020, Retina Group of Florida joined Retina Consultants of America, a national network of elite retina practices.

Differentiator

Problem solved

Functional benefit

Products and services

• Retina Specialty Medical Care

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered flagship and core.

• Retina Consultants of AmericaflagshipStrategic or Co-development Partner · 1 January 2020In 2020, Retina Group of Florida joined forces with fellow premier retina-only practices across the country to form Retina Consultants of America. This collaboration provides access to expanded research, extensive clinical trials, and state-of-the-art retinal care capabilities.
• Retina Consultants of Southwest FloridacoreStrategic or Co-development PartnerRetina Group of Florida acquired/merged with Retina Consultants of Southwest Florida, bringing additional physicians including Dr. Ashish G. Sharma, Dr. Katrina A. Mears, and Dr. Paul A. Raskauskas into the practice in 2025.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• California Retina Consultants: Large retina-only ophthalmology practice on the West Coast and fellow member of the Retina Consultants of America network. Comparable in specialty focus, clinical trial activity, and multi-location model.
• Charles Retina Institute: Memphis-based retina specialty practice offering vitreoretinal surgery and clinical trials. Comparable single-specialty focus and physician-driven academic credentials.
• Mid Atlantic Retina: Large retina specialty group serving the Mid-Atlantic region with multiple locations and active clinical research. Closest scale comparable in the Eastern US.
• Austin Retina Associates: Multi-location Texas retina practice with active clinical research program and fellowship training, similar in specialty depth and community-based delivery model.
• Vitreoretinal Consultants: Long-established New York-area retina specialty practice offering medical and surgical vitreoretinal care with research activity. Comparable single-specialty depth.
• New England Retina Associates: Regional retina specialty group serving the New England market with multi-office coverage. Comparable single-specialty retina positioning and clinical research.
• Retina Associates of Cleveland: Multi-physician retina specialty practice in Ohio with a long operating history and active clinical trials. Directly comparable in scope and structure.

Broad incumbents

• Bascom Palmer Eye Institute: University of Miami-affiliated eye hospital ranked #1 in the US, where many RGF physicians trained. Broader incumbent offering all ophthalmology subspecialties plus research and academic training.
• Wills Eye Hospital: Philadelphia-based specialty eye hospital and one of the oldest ophthalmology institutions in the US. Provides training pedigree for several RGF physicians and competes in the broader retina space.
• Wilmer Eye Institute: Johns Hopkins-affiliated academic eye institute providing full-scope ophthalmology, retina surgery, and clinical research. Represents the academic incumbent benchmark in retina care.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/retinagroup_fl

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Group of Florida